Christof Marré
About Christof Marré
Christof Marré serves as the VP of Marketing & Pipeline Planning at Alpine Immune Sciences, Inc., where he has significantly contributed to the company's growth and strategic positioning. With extensive experience in the pharmaceutical industry, he has held various leadership roles at notable companies including EMD Serono, Biogen Idec, and Bristol-Myers Squibb.
Current Role at Alpine Immune Sciences
Christof Marré serves as the Vice President of Marketing & Pipeline Planning at Alpine Immune Sciences, Inc. since 2023. In this role, he operates remotely from Seattle, Washington. He was the first commercial hire at the company, reporting directly to the Chief Business Officer. Marré has established the company's presence at various conferences and has built relationships with leading Key Opinion Leaders across seven different indications.
Previous Experience in the Pharmaceutical Industry
Marré has extensive experience in the pharmaceutical industry, having held several key positions. He worked at EMD Serono, Inc. as VP, Global Brand Lead for Rebif from 2016 to 2020 and as VP, Global Launch Lead for Neurology & Immunology from 2020 to 2022. Prior to that, he was Vice President of Neurology Marketing at Biogen Idec for one year and Director of Oncology Marketing at Bristol-Myers Squibb for six years.
Consulting Background
Before transitioning to the pharmaceutical sector, Marré worked in consulting. He was a Senior Consultant at The Boston Consulting Group from 1995 to 1998 in the Düsseldorf Area, Germany. Earlier in his career, he worked as a Consultant at Monitor Group in London from 1993 to 1995. His consulting experience has contributed to his strategic approach in subsequent roles within the industry.
Educational Qualifications
Marré holds a Master of Science in Economics from The London School of Economics and Political Science, where he studied from 1991 to 1993. He also studied at The University of Bonn, achieving a Vordiplom in Economics from 1989 to 1990. His educational background has provided a strong foundation for his career in marketing and strategy within the pharmaceutical industry.
Key Achievements in Pipeline Development
Marré played a significant role in advancing the lead asset, povetacicept, from pre-Phase I to Phase III readiness in just 15 months. His strategic leadership has been instrumental in the development and positioning of pharmaceutical products, contributing to the overall success of the organizations he has been part of.